VitaDAO (VITA) Increases By 60% As The Firm Announcing $4.1 Million Fundraising
Key Points:
- VitaDAO plans to use the funds to support lifespan research initiatives and biotech firms produced out of DAO next year.
- The VitaDAO governance Token VITA increased by 60% in a short amount of time as a result of the announcement.
- VitaDAO has financed more than 15 projects to study ageing disorders for a total of more than $3.5 million in the last year.
VitaDAO, a DeSci track longevity startup, announced the completion of a $4.1 million funding round on January 30th, led by Balaji Srinivasan, former CTO of Coinbase, and Pfizer Ventures, the investment arm of Pfizer, the world’s largest pharmaceutical company. This is Pfizer’s first investment in the Web3 space.
According to the announcement, VitaDAO plans to use the funds to support lifespan research initiatives and biotech firms produced out of DAO next year.
DeSci (Decentralised Science) is a program that aims to build a public infrastructure for the fair and equitable funding, development, review, crediting, storage, and dissemination of scientific information through the use of Web3 techniques such as NFT, smart contracts, and DAO.
While humanity has experienced an exponential wave of technological development in the last two centuries, there are still various financial and information access barriers in reality, and the combination of technology and Web3 may be one way to address the pain points
The blog spot said
In a show about decentralized science, Ethereum founder Vitalik Buterin also discussed the usage of quadratic funding and DAO tools like VitaDAO to fund and organize scientific endeavours.
VitaDAO has financed more than 15 projects to study ageing disorders for a total of more than $3.5 million in the last year, and these efforts by biotech firms or organizations to seek funding in the Web3 area can be considered a major breakthrough.
The VitaDAO governance Token VITA increased by more than 60% in a short amount of time as a result of the announcement of fundraising.
VitaDAO funds startups through traditional equity or by issuing and selling NFTs that represent intellectual property. DAO members become co-owners of the intellectual property developed by the research in exchange for research funding.
Besides, VitaDAO will not only give certain VITA Token incentives to researchers and working groups who contribute data or expertise, but will also provide additional governance privileges, as written in the blog post.
DISCLAIMER: The Information on this website is provided as general market commentary and does not constitute investment advice. We encourage you to do your own research before investing.
Join us to keep track of news: https://linktr.ee/coincu
Thana
Coincu News
Author
News
VitaDAO (VITA) Increases By 60% As The Firm Announcing $4.1 Million Fundraising
Key Points:
- VitaDAO plans to use the funds to support lifespan research initiatives and biotech firms produced out of DAO next year.
- The VitaDAO governance Token VITA increased by 60% in a short amount of time as a result of the announcement.
- VitaDAO has financed more than 15 projects to study ageing disorders for a total of more than $3.5 million in the last year.
VitaDAO, a DeSci track longevity startup, announced the completion of a $4.1 million funding round on January 30th, led by Balaji Srinivasan, former CTO of Coinbase, and Pfizer Ventures, the investment arm of Pfizer, the world’s largest pharmaceutical company. This is Pfizer’s first investment in the Web3 space.
According to the announcement, VitaDAO plans to use the funds to support lifespan research initiatives and biotech firms produced out of DAO next year.
DeSci (Decentralised Science) is a program that aims to build a public infrastructure for the fair and equitable funding, development, review, crediting, storage, and dissemination of scientific information through the use of Web3 techniques such as NFT, smart contracts, and DAO.
While humanity has experienced an exponential wave of technological development in the last two centuries, there are still various financial and information access barriers in reality, and the combination of technology and Web3 may be one way to address the pain points
The blog spot said
In a show about decentralized science, Ethereum founder Vitalik Buterin also discussed the usage of quadratic funding and DAO tools like VitaDAO to fund and organize scientific endeavours.
VitaDAO has financed more than 15 projects to study ageing disorders for a total of more than $3.5 million in the last year, and these efforts by biotech firms or organizations to seek funding in the Web3 area can be considered a major breakthrough.
The VitaDAO governance Token VITA increased by more than 60% in a short amount of time as a result of the announcement of fundraising.
VitaDAO funds startups through traditional equity or by issuing and selling NFTs that represent intellectual property. DAO members become co-owners of the intellectual property developed by the research in exchange for research funding.
Besides, VitaDAO will not only give certain VITA Token incentives to researchers and working groups who contribute data or expertise, but will also provide additional governance privileges, as written in the blog post.
DISCLAIMER: The Information on this website is provided as general market commentary and does not constitute investment advice. We encourage you to do your own research before investing.
Join us to keep track of news: https://linktr.ee/coincu
Thana
Coincu News
Other Posts
Related Posts
Latest
Pepeto’s $600K Presale Highlights Vision for Supporting Memecoins Ahead of 2025
Best Cryptos to Buy in November 2024: What Sets Qubetics Apart from Fantom and Immutable X?
Press Release
Pepeto’s $600K Presale Highlights Vision for Supporting Memecoins Ahead of 2025
Best Cryptos to Buy in November 2024: What Sets Qubetics Apart from Fantom and Immutable X?
